Cancer survival in five continents: a worldwide population-based study (CONCORD).

[1]  Christos Kremmydas.  Childhood , 2010, The Classical Review.

[2]  F. Berrino,et al.  Patient survival for all cancers combined as indicator of cancer control in Europe. , 2008, European journal of public health.

[3]  H. Weir,et al.  Life Tables for World-Wide Comparison of Relative Survival for Cancer (CONCORD Study) , 2008, Tumori.

[4]  F. Berrino,et al.  Influence of morphology on survival for non-Hodgkin lymphoma in Europe and the United States. , 2008, European journal of cancer.

[5]  Amy Y. Chen,et al.  Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis. , 2008, The Lancet. Oncology.

[6]  Hermann Brenner,et al.  Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. , 2007, The Lancet. Oncology.

[7]  Franco Berrino,et al.  Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. , 2007, The Lancet. Oncology.

[8]  M. Richards.  EUROCARE-4 studies bring new data on cancer survival. , 2007, The Lancet. Oncology.

[9]  Michael J. Wilson,et al.  Cathepsin B expression is similar in African-American and Caucasian prostate cancer patients. , 2007, Anticancer research.

[10]  Arianna Simonetti,et al.  Hepatocellular Carcinoma: Trends of Incidence and Survival in Europe and the United States at the End of the 20th Century , 2007, The American Journal of Gastroenterology.

[11]  M. Borre,et al.  [Screening for prostate cancer--what does the evidence show?]. , 2007, Ugeskrift for laeger.

[12]  R. Sankila,et al.  Interpreting international comparisons of cancer survival: the effects of incomplete registration and the presence of death certificate only cases on survival estimates. , 2007, European journal of cancer.

[13]  M. Borre,et al.  Screening for prostatacancer--hvad siger evidensen? , 2007 .

[14]  A. Bouvier,et al.  Survie des patients atteints de cancer en France , 2007 .

[15]  G. Launoy,et al.  Survival of cancer patients in France: a population-based study from The Association of the French Cancer Registries (FRANCIM). , 2007, European journal of cancer.

[16]  U. Ajani.  United States cancer statistics; 2004 incidence and mortality , 2007 .

[17]  A. Oshima,et al.  Survival of cancer patients diagnosed between 1993 and 1996: a collaborative study of population-based cancer registries in Japan. , 2006, Japanese journal of clinical oncology.

[18]  D. Parkin,et al.  The evolution of the population-based cancer registry , 2006, Nature Reviews Cancer.

[19]  R. De Angelis,et al.  Hodgkin disease survival in Europe and the U.S. , 2006, Cancer.

[20]  K. Brasso,et al.  [Prostatic cancer 2006--status and new challenges. The Danish Society of Urology]. , 2006, Ugeskrift for laeger.

[21]  K. Brasso,et al.  Prostatacancer 2006--status og nye udfordringer. Dansk Urologisk Selskab , 2006 .

[22]  E. Feuer,et al.  SEER Cancer Statistics Review, 1975-2003, National Cancer Institute. Bethesda, MD, , 2006 .

[23]  L. Woods.  International differences in breast cancer survival and "cure" by social deprivation : a comparative study of England and Australia. , 2006 .

[24]  E. Feuer,et al.  SEER Cancer Statistics Review, 1975-2003 , 2006 .

[25]  B Rachet,et al.  Origins of socio-economic inequalities in cancer survival: a review. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[26]  M. Coleman,et al.  Trends in cancer incidence and mortality. , 1993, IARC scientific publications.

[27]  David J Spiegelhalter,et al.  Funnel plots for comparing institutional performance , 2005, Statistics in medicine.

[28]  M. Coleman,et al.  Breast cancer survival in South Asian women in England and Wales , 2005, Journal of Epidemiology and Community Health.

[29]  M. Coleman,et al.  Choice of geographic unit influences socioeconomic inequalities in breast cancer survival , 2005, British Journal of Cancer.

[30]  M. Coleman,et al.  Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery , 2005, Gut.

[31]  H. Brenner,et al.  Cancer survival in a southern African urban population , 2004, International journal of cancer.

[32]  Susan Bolick-Aldrich,et al.  Rationale and design of the National Program of Cancer Registries' breast, colon, and prostate cancer patterns of care study , 2004, Cancer Causes & Control.

[33]  D. Forman,et al.  Comparison of cancer survival in UK and Australia: rates are higher in Australia for three major sites , 2004, British Journal of Cancer.

[34]  Mike Quinn,et al.  Standard cancer patient population for age standardising survival ratios. , 2004, European journal of cancer.

[35]  J. Cedarbaum.  Survival , 2004 .

[36]  F. Bray,et al.  The changing global patterns of female breast cancer incidence and mortality , 2004, Breast Cancer Research.

[37]  Ahmedin Jemal,et al.  Cancer Disparities by Race/Ethnicity and Socioeconomic Status , 2004, CA: a cancer journal for clinicians.

[38]  M. Coleman,et al.  Breast carcinoma survival in Europe and the United States , 2004, Cancer.

[39]  O. Osundeko,et al.  Unequal Treatment—Confronting Racial and Ethnic Disparities in Healthcare , 2004 .

[40]  E. Feuer,et al.  Projecting SEER cancer survival rates to the US: an ecological regression approach , 2002, Cancer Causes & Control.

[41]  M. Coleman,et al.  Survival of cancer patients in europe—The EUROCARE study , 1995, Cancer Causes & Control.

[42]  L. Garrote,et al.  Childhood cancer survival in Cuba , 2004, European Journal of Epidemiology.

[43]  J. Ferlay,et al.  Cancer incidence in five continents. Volume VI , 2004, Cancer Causes & Control.

[44]  F. Berrino.  The EUROCARE Study: strengths, limitations and perspectives of population-based, comparative survival studies. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[45]  E Carrani,et al.  The EUROCARE-3 database: methodology of data collection, standardisation, quality control and statistical analysis. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[46]  F Berrino,et al.  EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[47]  M. Coleman,et al.  EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[48]  M. Coleman,et al.  Cancer survival in Kentucky and health insurance coverage. , 2003, Archives of internal medicine.

[49]  M. Coleman,et al.  Differences in colorectal cancer survival between European and US populations: the importance of sub-site and morphology. , 2003, European journal of cancer.

[50]  M. Coleman,et al.  Cancer control in Europe: a proposed set of European cancer health indicators. , 2003, European journal of public health.

[51]  M. Mckee,et al.  Monitoring health in Europe: opportunities, challenges and progress. , 2003, European journal of public health.

[52]  P. Mangtani,et al.  Survival from breast cancer among South Asian and non-South Asian women resident in South East England , 2003, British Journal of Cancer.

[53]  W. Ajiki,et al.  Comparison of stomach cancer incidence and survival in four continents. , 2003, European journal of cancer.

[54]  Linda Rabeneck,et al.  Survival of colorectal cancer patients hospitalized in the Veterans Affairs Health Care System. , 2003 .

[55]  L. Abenhaim.  [Progress against cancer!]. , 2003, Revue d'epidemiologie et de sante publique.

[56]  G. Gatta,et al.  Childhood cancer survival in Europe. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

[57]  M. Coleman,et al.  Survival of cancer patients in Europe: the EUROCARE-3 study [Journal supplement issue] , 2003 .

[58]  G. Pichert,et al.  Evidence-based management options for women at increased breast/ovarian cancer risk. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[59]  J. Boos,et al.  Off label use--label off use? , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[60]  David P. Smith,et al.  Cancer survival, incidence and mortality by Area Health Service in NSW 1994 to 2000 , 2003 .

[61]  M. Coleman,et al.  Childhood cancer survival in Europe and the United States , 2002, Cancer.

[62]  E. Ossiander,et al.  Socioeconomic and demographic disparities in treatment for carcinomas of the colon and rectum , 2002, Cancer.

[63]  S. Hasan,et al.  Comparability and Quality Control in Cancer Registration; Karachi (data monitoring 1995-2001). , 2002, JPMA. The Journal of the Pakistan Medical Association.

[64]  Colin B Begg,et al.  Survival of blacks and whites after a cancer diagnosis. , 2002, JAMA.

[65]  O. Brawley.  Disaggregating the effects of race and poverty on breast cancer outcomes. , 2002, Journal of the National Cancer Institute.

[66]  Cathy J Bradley,et al.  Race, socioeconomic status, and breast cancer treatment and survival. , 2002, Journal of the National Cancer Institute.

[67]  V. Shavers,et al.  Racial and ethnic disparities in the receipt of cancer treatment. , 2002, Journal of the National Cancer Institute.

[68]  B. Smedley,et al.  Unequal Treatment: Con-fronting Racial and Ethnic Disparities in Health Care , 2002 .

[69]  K. Gorey,et al.  An international comparison of cancer survival: relatively poor areas of Toronto, Ontario and three US metropolitan areas. , 2000, Journal of public health medicine.

[70]  M. Coleman,et al.  Toward a comparison of survival in American and European cancer patients , 2000, Cancer.

[71]  D. Wingard,et al.  Trends in breast cancer incidence, survival, and mortality , 2000, The Lancet.

[72]  J. Dignam.  Differences in breast cancer prognosis among African‐American and Caucasian women , 2000, CA: a cancer journal for clinicians.

[73]  J. Ferlay,et al.  Erratum: Estimates of the worldwide mortality from 25 cancers in 1990. Int. J. Cancer, 83, 18–29 (1999). , 1999, International journal of cancer.

[74]  D. Wickerham,et al.  Outcomes among African-Americans and Caucasians in colon cancer adjuvant therapy trials: findings from the National Surgical Adjuvant Breast and Bowel Project. , 1999, Journal of the National Cancer Institute.

[75]  O. Brawley,et al.  Race and outcomes: is this the end of the beginning for minority health research? , 1999, Journal of the National Cancer Institute.

[76]  J. Ferlay,et al.  Estimates of the worldwide mortality from 25 cancers in 1990 , 1999, International journal of cancer.

[77]  R. Sankaranarayanan.  Cancer Survival in Developing Countries , 1998 .

[78]  S. Friis,et al.  Prostate cancer in Denmark: a 50-year population-based study. , 1998, Urology.

[79]  K. Gorey,et al.  An international comparison of cancer survival: advantage of Toronto's poor over the near poor of Detroit. , 1998, Canadian journal of public health = Revue canadienne de sante publique.

[80]  Black Rj,et al.  World standard cancer patient populations: a resource for comparative analysis of survival data. , 1998 .

[81]  D. Parkin,et al.  An overview of cancer survival in developing countries. , 1998, IARC scientific publications.

[82]  M. Stolte,et al.  Differences in the diagnostic criteria used by japanese and western pathologists to diagnose colorectal carcinoma , 1998, Cancer.

[83]  J. Silverman,et al.  Pathology of the malignant colorectal polyp. , 1998, Human pathology.

[84]  Y. Galán Alvarez,et al.  Cancer survival in Cuba. , 1998, IARC scientific publications.

[85]  A. Engeland,et al.  Relative survival of cancer patients--a comparison between Denmark and the other Nordic countries. , 1998, Acta oncologica.

[86]  R. Black,et al.  World standard cancer patient populations: a resource for comparative analysis of survival data. , 1998, IARC scientific publications.

[87]  C. F. Brockington.  Demographic yearbook 1992: the disease picture of the developed and developing worlds compared. , 1997, Public health.

[88]  M. Kogevinas,et al.  Social inequalities and cancer , 1997 .

[89]  J C Bailar,et al.  Cancer undefeated. , 1997, The New England journal of medicine.

[90]  Jacques Ferlay,et al.  Cancer incidence in five continents, Volume IX. , 1982 .

[91]  M. Kogevinas,et al.  Socioeconomic differences in cancer survival: a review of the evidence. , 1997, IARC scientific publications.

[92]  R. Sankaranarayanan,et al.  Global variations in cancer survival , 1996 .

[93]  W. Hunt,et al.  Regional variation in survival following the diagnosis of cancer. , 1996, Journal of clinical epidemiology.

[94]  N. Polissar,et al.  Race, socioeconomic status and survival in three female cancers. , 1996, Ethnicity & health.

[95]  C. Redmond,et al.  Determinants of black/white differences in colon cancer survival. , 1995, Journal of the National Cancer Institute.

[96]  H. Brenner.  Limitations of the death certificate only index as a measure of incompleteness of cancer registration , 1995, British Journal of Cancer.

[97]  D. Ansell,et al.  Race, income, and survival from breast cancer at two public hospitals , 1993, Cancer.

[98]  L. Bernstein,et al.  Stage and delay in breast cancer diagnosis by race, socioeconomic status, age and year. , 1992, British Journal of Cancer.

[99]  R. Doll,et al.  Comparison between registries: age-standardized rates , 1992 .

[100]  R. Doll,et al.  Are we winning the war against cancer? A review in memory of Keith Durrant. , 1992, Clinical oncology (Royal College of Radiologists (Great Britain)).

[101]  J. Nectoux,et al.  Temporal change in diagnostic criteria as a cause of the increase of malignant melanoma over time is unlikely , 1991, International journal of cancer.

[102]  J. Estève,et al.  Relative survival and the estimation of net survival: elements for further discussion. , 1990, Statistics in medicine.

[103]  R. Doll,et al.  Are we winning the fight against cancer? An epidemiological assessment. EACR--Mühlbock memorial lecture. , 1990, European Journal of Cancer.

[104]  E. Sondik.  Measurement of progress against cancer. Extramural Committee to Assess Measures of Progress Against Cancer. , 1990, Journal of the National Cancer Institute.

[105]  R. Doll.  Progress against cancer: are we winning the war? , 1989, Acta oncologica.

[106]  D. L. Sobin,et al.  Histological Typing of Intestinal Tumours , 1989, World Health Organization.

[107]  J. Young,et al.  Cancer patient survival among ethnic groups in the United States. , 1984, Journal of the National Cancer Institute.

[108]  T. Hakulinen.  A comparison of nationwide cancer survival statistics in Finland and Norway. , 1983, World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales.

[109]  T. Hakulinen,et al.  Cancer survival corrected for heterogeneity in patient withdrawal. , 1982, Biometrics.

[110]  R. Weller,et al.  International Histological Classification of Tumours , 1981 .

[111]  C. Percy,et al.  Comparison of the coding of death certificates related to cancer in seven countries. , 1978, Public health reports.

[112]  I. Dawson.  Histological Typing of Intestinal Tumours. International Histological Classification of Tumours , 1977 .

[113]  T. Hakulinen.  On long-term relative survival rates. , 1977, Journal of chronic diseases.

[114]  A. Adelstein.  Studies on medical and population subjects. , 1976 .

[115]  L. Garfinkel,et al.  Apparent changes in cancer mortality, 1968. A study of the effects of the introduction of the Eighth Revision International Classification of Diseases. , 1974, Public health reports.

[116]  J. Ferlay,et al.  Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.

[117]  Richard Doll,et al.  Cancer incidence in five continents : a technical report , 1966 .

[118]  F. Ederer,et al.  The relative survival rate: a statistical methodology. , 1961, National Cancer Institute monograph.

[119]  F. Ederer,et al.  Maximum utilization of the life table method in analyzing survival. , 1958, Journal of chronic diseases.

[120]  N. Mccormick.  A report on the survival of the patients treated for cancer from 1935 to 1947 inclusive. , 1953, Canadian Medical Association journal.

[121]  J BERKSON,et al.  Calculation of survival rates for cancer. , 1950, Proceedings of the staff meetings. Mayo Clinic.

[122]  S. Wyard,et al.  THE NATURAL DURATION OF CANCER , 1925, Canadian Medical Association journal.

[123]  W. S. Lazarus-Barlow,et al.  THE NATURAL DURATION OF CANCER , 1924, British medical journal.